{
    "links": "https://www.ycombinator.com/companies/64x-bio",
    "name": "64x Bio",
    "headline": "High throughput design of cells for therapeutics applications.",
    "batch": "S18",
    "description": "64x Bio is building a platform that radically increases the speed and scale of mammalian cell line discovery. Using a novel high throughput discovery and screening platform and an integrated computational design loop, we are developing new ways of generating highly optimized and otherwise unattainable cell lines for the manufacturing of viral vectors, with a specific focus on those used for cell and gene therapies. \r\n\nOur platform technology enables pharmaceutical and biotechnology companies to bring cell and gene therapies to patients more effectively, providing purpose-built genetically engineered cell lines to increase the efficiency of viral vector production and reduce the cost of manufacturing.",
    "activity_status": "Active",
    "website": "http://www.64xbio.com",
    "founded_date": 2017.0,
    "team_size": 25.0,
    "location": "San Francisco",
    "group_partner": null,
    "group_partner_yc": null,
    "company_linkedin": null,
    "company_twitter": null,
    "tags": "industry:gene-therapy; industry:machine-learning; location:san-francisco-bay-area",
    "founders": [],
    "status": true,
    "generated_description": "**64x Bio: Revolutionizing Gene Therapies**\n\nFounded in 2017 and part of Y Combinator's Batch S18, 64x Bio is a San Francisco-based innovator in the biotech landscape, focused on advancing cell and gene therapies. With a team of 25 dedicated professionals, their mission is clear: to accelerate the design and discovery of mammalian cell lines at unprecedented speed and scale.\n\nAt the heart of 64x Bio\u2019s operations is a cutting-edge high-throughput discovery platform that blends genome engineering with computational design. This integrated approach allows for the creation of highly optimized cell lines that are crucial for producing viral vectors used in gene and cell therapies. What does this mean? Essentially, they\u2019re making it faster and cheaper for pharmaceutical companies to develop therapies that can change lives.\n\nTheir technology not only improves the efficiency of viral vector production but also significantly lowers manufacturing costs. This dual advantage is pivotal in pushing the boundaries of what's possible in treatment options for patients worldwide.\n\nIn a nutshell, 64x Bio stands at the intersection of biotechnology and machine learning, using advanced engineering techniques to reshape the future of therapeutic development. As they continue to innovate, their platform could prove pivotal in making gene therapies more accessible and effective, thereby fulfilling the urgent need for breakthroughs in treatment options for various diseases.\n\nYou can learn more about their groundbreaking work on their [website](http://www.64xbio.com) and keep up with their latest developments on platforms like LinkedIn and Twitter.",
    "logo": "https://bookface-images.s3.us-west-2.amazonaws.com/logos/3294141f8b8bffcbb5abb0432a82855e7ed8488c.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAQC4NIECAJMV6TLGB%2F20250221%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20250221T190937Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJGMEQCIFLa1ybFb1MW3YWarl6N2DZLtQ4R6h64JtRzg2nxAowaAiB3nTk9Wj2wgaQBuQdmXKSYUK01s%2FfzNcIsI%2FpnnVYrDCruAwjc%2F%2F%2F%2F%2F%2F%2F%2F%2F%2F8BEAAaDDAwNjIwMTgxMTA3MiIMbK4eHGyZbeOmKiEOKsIDEgeFqYzoIm9WYPES%2BanLfTcQEGyzIks%2Fal2Lmqxe4p56ewXYsETQE6xKLCXrmvzZNyUDpx5dtkyRoWAO6FYyXXGaPQzEZ3lyFdj%2BxmzYPjn73zyfO0POWT06n60Ss4FWi%2BsXTCqzCDlztmj5P3pe%2BccFf3AJ6Fob0iUEcgWZg86XqS2niw4lXPnalb%2Boq3NuXvHl2oVLzjcW3kqbNIZD4bJeuP%2BaiX3YtJ%2BJXjqRV4JMYzbegC89ld8%2FQ6Niu9GP6iWyA3Ij%2Frc6v9eF94GLnVFmDUIq%2FgOldm3US8WLOYW64cbfEYgRv4%2BZqFOZik7gMqvr0%2BAMO66zctStkeS7pQEndome2HMXzolZnAHIKHa7syJwRucmMBn1qLVqGHDFwDTWD66ZqASdClXaJEb6qKYFGBQM0HPz9IZYPkFD7FlZyifcWNrFEjlM4LJiyAQcunx30b5EMcz8oT7YjYIo5Bb2DOsnIt6uAdkOmUPUmY%2FzM3PmuL6ZYePw7XBzfBYcfiNqZPHWFO6x0%2FmP5sl5TFTspcBFiC1tU5q9L40pvlUpeAHA0lByHoziRM9b9aIUnBzO8cEmGGLYvEv9AlDEIduUMLKL470GOqYBeuzvU%2B1K1xvzamOk1TaDeko%2BJlQ8xUgcguCKvnE%2BpYSn9MQz0SIXrm4hUrSnIO%2FjFoTZ4esBSlXTCkXH%2F6%2BRHttOAoEAfv1XQWO8%2Bsv2qVS97SrODEBLVhY1tfEFQcw%2BZ93GUo5LYHe1U2PubGkf9wTLJ5AZCq5Vr1%2FKLwVlulVfHEhtz4E3fzOL1TPO7tIclZor0kZmzjAwtkky7VHrQVXehNV3Gw%3D%3D&X-Amz-SignedHeaders=host&X-Amz-Signature=edc9a8278683b39caf62b6a787d56298d728e77330c16a343d1066880e7acfdd",
    "social_links": [
        "https://www.linkedin.com/company/64xbio",
        "https://twitter.com/64xbio",
        "https://www.facebook.com/64xbio"
    ],
    "logo_path": "data/logos\\64x_Bio_logo.png"
}